Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy.
Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy.
复制标题
血浆三甲胺 N 氧化物水平升高与糖尿病视网膜病变相关
DOI:
10.1007/s00592-020-01610-9
复制
发表时间:
2021-03
影响因子:
3.8
通讯作者:
Lu P
中科院分区:
文献类型:
--
作者:
Liu W;Wang C;Xia Y;Xia W;Liu G;Ren C;Gu Y;Li X;Lu P
To determine the relationship between plasma levels of trimethylamine-N-oxide (TMAO) and odds of diabetic retinopathy (DR). A cross-sectional study was conducted. Blood samples were obtained from 122 type 2 diabetes mellitus (T2DM) patients with or without DR. Multivariable logistic regression analyses were performed to identify the association between plasma TMAO and DR. The diagnostic value of plasma TMAO was assessed by the area under the receiver operating characteristic curve (AUROC) and integrated discrimination improvement (IDI). In the T2DM patients, plasma levels of TMAO were significantly higher in patients with DR compared with those without DR (P = 0.001). As logarithmic (ln) transformation of TMAO increased per standard deviation (SD), there was higher probability to have DR [odds ratio (OR) = 2.31; P = 0.005]. As ln-transformed TMAO increased per SD, the severity of DR was more likely to get worse (OR = 2.05; P = 0.004). In the diagnostic model, the addition of TMAO contributed to the improvement in AUROC from 0.646 to 0.734 (P = 0.043), and the IDI was 10.7% (P < 0.001). Elevated levels of plasma TMAO were associated with higher odds and worse severity of DR in T2DM patients, and further investigation is required for the causality of this association.
登录
查看更多内容
影响因子:
24.5
作者:
Heianza Y;Sun D;Li X;DiDonato JA;Bray GA;Sacks FM;Qi L
通讯作者:
Qi L
影响因子:
5.6
作者:
Singh, Gurinder Bir;Zhang, Yang;Koka, Saisudha
通讯作者:
Koka, Saisudha
DOI:
10.1161/atvbaha.119.312592
发表时间:
2019-06-01
影响因子:
8.7
作者:
Shih, Diana M.;Zhu, Weifei;Lusis, Aldons J.
通讯作者:
Lusis, Aldons J.
影响因子:
82.9
作者:
Roberts AB;Gu X;Buffa JA;Hurd AG;Wang Z;Zhu W;Gupta N;Skye SM;Cody DB;Levison BS;Barrington WT;Russell MW;Reed JM;Duzan A;Lang JM;Fu X;Li L;Myers AJ;Rachakonda S;DiDonato JA;Brown JM;Gogonea V;Lusis AJ;Garcia-Garcia JC;Hazen SL
通讯作者:
Hazen SL
影响因子:
39.2
作者:
Levey AS;Stevens LA;Schmid CH;Zhang YL;Castro AF 3rd;Feldman HI;Kusek JW;Eggers P;Van Lente F;Greene T;Coresh J;CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
通讯作者:
CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)